TAKE Solutions Limited (TAKE.NS)

INR 16.9

(0.3%)

EBITDA Summary of TAKE Solutions Limited

  • TAKE Solutions Limited's latest annual EBITDA in 2023 was -1.05 Billion INR , down -27.25% from previous year.
  • TAKE Solutions Limited's latest quarterly EBITDA in 2023 FY was N/A , down -27.25% from previous quarter.
  • TAKE Solutions Limited reported an annual EBITDA of -209.79 Million INR in 2022, down -123.32% from previous year.
  • TAKE Solutions Limited reported an annual EBITDA of 269 Million INR in 2021, up 222.13% from previous year.
  • TAKE Solutions Limited reported a quarterly EBITDA of -152.18 Million INR for 2023 Q4, down -1441.98% from previous quarter.
  • TAKE Solutions Limited reported a quarterly EBITDA of N/A for 2023 FY, down -27.25% from previous quarter.

Annual EBITDA Chart of TAKE Solutions Limited (2023 - 2006)

Historical Annual EBITDA of TAKE Solutions Limited (2023 - 2006)

Year EBITDA EBITDA Growth
2023 -1.05 Billion INR -27.25%
2022 -209.79 Million INR -123.32%
2021 269 Million INR 222.13%
2020 -2.86 Billion INR -118.84%
2019 1.95 Billion INR -48.86%
2018 3.94 Billion INR 27.22%
2017 3.12 Billion INR 19.85%
2016 2.75 Billion INR 22.47%
2015 1.62 Billion INR 38.15%
2014 1.08 Billion INR -2.2%
2013 964.8 Million INR -5.21%
2012 1.61 Billion INR 4.74%
2011 1.45 Billion INR 19.68%
2010 1.09 Billion INR 60.26%
2009 714.57 Million INR -12.71%
2008 809.87 Million INR 5.24%
2007 874.58 Million INR 70.19%
2006 472.32 Million INR 0.0%

Peer EBITDA Comparison of TAKE Solutions Limited

Name EBITDA EBITDA Difference
Biocon Limited 41.52 Billion INR 102.531%
Blue Jet Healthcare Limited 2.29 Billion INR 145.842%
Concord Biotech Limited 4.65 Billion INR 122.555%
Dishman Carbogen Amcis Limited 3.07 Billion INR 134.209%
Jubilant Ingrevia Limited 4.56 Billion INR 123.023%
Lyka Labs Limited 167.58 Million INR 727.034%
Panacea Biotec Limited -47.58 Million INR -2108.575%
Piramal Pharma Limited 13.05 Billion INR 108.049%
SMS Lifesciences India Limited 349.41 Million INR 400.747%
Supriya Lifescience Limited 1.83 Billion INR 157.243%
Syngene International Limited 10.84 Billion INR 109.688%
Zota Health Care Limited 82.07 Million INR 1380.372%